Sublingual Oxytocin for the Prevention of Post-partum Hemorrhage
Clinical trial NCT06968481 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06968481
- Sponsor
- Insud Pharma
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-30
- Primary completion
- 2026-10-30
- Enrollment
- 330
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.